John Jubinsky


Dundalk, MD

United States

Comment Wall:

Load Previous Comments
  • Chris

    Thanks John,

    Ancestory groups that check lineage by name of course results in some errors. My mother checked her maternal liniage back to ~1600.

    Family lineage says I'm from North Ireland among other places depending upon how far back studies go.

    Here's the beginning of some human links on youtube  you probably already know about.

    Ultamately we are all related to amobeas.

  • Chris

    Hi John,

    Have you seen  The Spread of the Indo-Europeans and do any of the DNA ancestory tests check for this lineage?

  • Chris

    Hi John,

    How much information was proviided by the DNA tests you had?   Did any of the testers provide you with a type of map of your DNA lineage?   The little I know, which is almost none except for TV commercials indicate that the tests don't disgunguish very many different groups.

    I see DNA tests being advertized as xtmas gifts. 

    When you had your DNA testing done did the test results provide information about mutations?

    Commercial DNA Testing May Cause Harm, Scientific Studies Show (if You Read Through to the Study Limitations at the End)

    A year after the US Food and Drug Administration urged 23andMe to stop the marketing of its personal genome test in the United States, the world’s largest direct-to-consumer genetics company relaunched the test in Canada and the United Kingdom.

    “Find out how your genetics relate to things like abnormal blood clotting, cystic fibrosis or response to certain medications.” [italics added] “Keep in mind that many conditions and traits are influenced by multiple factors. Our reports are intended for informational purposes only and do not diagnose disease or illness.”

    The UK website of 23andMe opens with clarifying statements about how the company wants us to see their renewed test. “The UK Medicines and Healthcare Products Regulatory Agency ... has determined that we’re not a medical product, more an information product,” says 23andMe’s CEO Anne Wojcicki in The Guardian.

    As it seems, 23andMe has relaunched its DNA test as the information service it was in the beginning: a service that offers a personalized exploration about what science knows about your genes, how they relate to your health and what they tell about your characteristics and traits. Yet, the test itself has not been scaled back to what it was in the early days.

    The test now includes highly predictive variants such as BRCA1/2 genes mutations for breast and ovarian cancer, and variants in the APOE gene for Alzheimer’s disease and the LRKK2 gene for Parkinson disease.

    Clinical geneticists argue already for decades that testing highly predictive variants should be accompanied by adequate pre-and post-test information and counseling to help individuals understand and deal with the information. Testing such highly predictive gene variants directly to consumers may cause distress and anxiety when the initial fascination with the broader DNA test is gone.

    More in the link